These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 32823395)

  • 1. Human immunodeficiency virus and intraocular inflammation in the era of highly active anti retroviral therapy - An update.
    Sudharshan S; Nair N; Curi A; Banker A; Kempen JH
    Indian J Ophthalmol; 2020 Sep; 68(9):1787-1798. PubMed ID: 32823395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ophthalmic manifestations of HIV in the highly active anti-retroviral therapy era.
    Mowatt L
    West Indian Med J; 2013; 62(4):305-12. PubMed ID: 24756590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune recovery uveitis in AIDS patients with cytomegalovirus retinitis treated with highly active antiretroviral therapy in Venezuela.
    Arevalo JF; Mendoza AJ; Ferretti Y
    Retina; 2003 Aug; 23(4):495-502. PubMed ID: 12972761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV-associated retinopathy in the HAART era.
    Goldberg DE; Smithen LM; Angelilli A; Freeman WR
    Retina; 2005; 25(5):633-49; quiz 682-3. PubMed ID: 16077362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uveitis as an initial manifestation of acquired immunodeficiency syndrome.
    Tsen CL; Chen SC; Chen YS; Sheu SJ
    Int J STD AIDS; 2017 Oct; 28(12):1224-1228. PubMed ID: 28201950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ocular syphilis in patients with human immunodeficiency virus/acquired immunodeficiency syndrome in the era of highly active antiretroviral therapy.
    Sudharshan S; Menia NK; Selvamuthu P; Tyagi M; Kumarasamy N; Biswas J
    Indian J Ophthalmol; 2020 Sep; 68(9):1887-1893. PubMed ID: 32823409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytomegalovirus retinitis in the era of highly active antiretroviral therapy.
    Whitcup SM
    JAMA; 2000 Feb; 283(5):653-7. PubMed ID: 10665706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune recovery vitritis and uveitis in AIDS: clinical predictors, sequelae, and treatment outcomes.
    Karavellas MP; Azen SP; MacDonald JC; Shufelt CL; Lowder CY; Plummer DJ; Glasgow B; Torriani FJ; Freeman WR
    Retina; 2001; 21(1):1-9. PubMed ID: 11217922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Challenges in Treating Intraocular Inflammation in HIV Patients.
    Testi I; Ahmed S; Shah C; Agrawal R
    Ocul Immunol Inflamm; 2020 Oct; 28(7):1094-1098. PubMed ID: 32159416
    [No Abstract]   [Full Text] [Related]  

  • 10. Immune recovery uveitis: an ocular manifestation in HIV/AIDS receiving treatment.
    Dionson MM
    Curr Opin Ophthalmol; 2024 Nov; 35(6):507-512. PubMed ID: 39046420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ocular manifestations of AIDS: new considerations for patients using highly active anti-retroviral therapy (HAART).
    Roels P
    Optometry; 2004 Oct; 75(10):624-8. PubMed ID: 15508863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ophthalmic manifestations of HIV: an update.
    DeGrezia MG; Robinson M
    J Assoc Nurses AIDS Care; 2001; 12(3):22-32. PubMed ID: 11387803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ocular involvement in highly treatment-experienced patients with HIV.
    Cobaschi M; Dorobăț CM; Dorobăț VD; Loghin II; Macovei ML; Marinescu A; Aramă V
    Rom J Ophthalmol; 2024; 68(2):152-157. PubMed ID: 39006338
    [No Abstract]   [Full Text] [Related]  

  • 14. Discontinuation of anticytomegalovirus therapy in patients with HIV infection and cytomegalovirus retinitis.
    Whitcup SM; Fortin E; Lindblad AS; Griffiths P; Metcalf JA; Robinson MR; Manischewitz J; Baird B; Perry C; Kidd IM; Vrabec T; Davey RT; Falloon J; Walker RE; Kovacs JA; Lane HC; Nussenblatt RB; Smith J; Masur H; Polis MA
    JAMA; 1999 Nov; 282(17):1633-7. PubMed ID: 10553789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ocular manifestations of HIV infection.
    Jabs DA
    Trans Am Ophthalmol Soc; 1995; 93():623-83. PubMed ID: 8719695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The role of HIV associated eye changes in the time of HAART (highly active antiretroviral therapy].
    Garweg JG; Barloggio A
    Ther Umsch; 2001 Jan; 58(1):21-7. PubMed ID: 11217483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune recovery uveitis: a focus review.
    Rodrigues Alves N; Barão C; Mota C; Costa L; Proença RP
    Graefes Arch Clin Exp Ophthalmol; 2024 Aug; 262(8):2703-2712. PubMed ID: 38381160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Ocular manifestations in patients with human immunodeficiency virus infection before and after the introduction of highly active antiretroviral therapy].
    Mesarić B; Lisić M; Kniewald T; Ugrinović N; Begovac J
    Lijec Vjesn; 2005; 127(5-6):123-8. PubMed ID: 16281473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ophthalmic manifestations of HIV infections in India in the era of HAART: analysis of 100 consecutive patients evaluated at a tertiary eye care center in India.
    Gharai S; Venkatesh P; Garg S; Sharma SK; Vohra R
    Ophthalmic Epidemiol; 2008; 15(4):264-71. PubMed ID: 18780260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ocular Manifestations in Patients with Human Immunodeficiency Virus Infection in the Pre-HAART Versus the HAART Era in the North Indian Population.
    Agarwal A; Singh R; Sharma A; Gupta V; Dogra MR
    Ocul Immunol Inflamm; 2017 Jun; 25(3):396-404. PubMed ID: 26910292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.